Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 100 mg
Send MessageCanagliflozin Tablets are a next-generation oral antidiabetic formulation belonging to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class, specifically developed for effective management of type 2 diabetes mellitus. This advanced therapy works by reducing renal glucose reabsorption, thereby increasing urinary glucose excretion and lowering blood glucose levels in a controlled and insulin-independent manner.
In addition to glycemic control, Canagliflozin is widely recognized for its added benefits in supporting cardiovascular health, reducing body weight, and improving overall metabolic outcomes in diabetic patients. It is frequently included in modern diabetes management protocols due to its dual benefits in glucose control and cardiometabolic risk reduction.
Genliva Wellness LLP, Himatnagar, India, stands as a reliable canagliflozin tablets manufacturer India pharma and SGLT2 inhibitor tablets exporter India, delivering premium-quality formulations produced in WHO-GMP compliant facilities. The company caters to hospitals, endocrinology clinics, distributors, and international pharmaceutical partners seeking high-quality antidiabetic tablets supplier India with global export capabilities.
Canagliflozin tablets are formulated as an SGLT2 inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine. The formulation works independently of insulin and supports overall metabolic control.
This medication is used in the management of type 2 diabetes mellitus to improve glycemic control and support metabolic health.
The formulation offers a unique glucose-lowering approach through renal pathways, supporting effective diabetes management with added metabolic benefits.
